Clinical Trial Update: bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for bLAC evaluating treatment of cutaneous warts in immune-suppressed kidney transplant patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Warts

Drugs mentioned

• bLAC

Snippet

Sponsor: NatImmune A/S | Conditions: Cutaneous Warts | Phase 2 | Status: UNKNOWN